What Is the Optimal Model to Estimate the Benefits of Chemotherapy in Patients With Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer?

被引：1
作者：
Ando, Kenju [1 ]
Shimomura, Akihiko [1 ]
Yoshimura, Kenichi [2 ]
Kawamura, Yukino [1 ]
Shimizu, Chikako [1 ]
机构：
[1] Natl Ctr Global Hlth & Med, Dept Breast & Med Oncol, Shinjuku Ku, Tokyo, Japan
[2] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Minami Ku, Hiroshima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 17期
关键词：
WOMEN;
D O I：
10.1200/JCO.21.00178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1946 / +
页数：3
相关论文
共 8 条
  • [1] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [2] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
    Fisher, B
    Dignam, J
    Wolmark, N
    DeCillis, A
    Emir, B
    Wickerham, DL
    Bryant, J
    Dimitrov, NV
    Abramson, N
    Atkins, JN
    Shibata, H
    Deschenes, L
    Margolese, RG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1673 - 1682
  • [3] Kalinsky K, 2020, 2020 SAN ANT BREAST
  • [4] Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
    Pagani, Olivia
    Francis, Prudence A.
    Fleming, Gini F.
    Walley, Barbara A.
    Viale, Giuseppe
    Colleoni, Marco
    Lang, Istvan
    Gomez, Henry L.
    Tondini, Carlo
    Pinotti, Graziella
    Di Leo, Angelo
    Coates, Alan S.
    Goldhirsch, Aron
    Gelber, Richard D.
    Regan, Meredith M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1293 - +
  • [5] Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative
    Shadyab, Aladdin H.
    Macera, Caroline A.
    Shaffer, Richard A.
    Jain, Sonia
    Gallo, Linda C.
    Gass, Margery L. S.
    Waring, Molly E.
    Stefanick, Marcia L.
    LaCroix, Andrea Z.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (01): : 35 - 44
  • [6] Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
    Sparano, J. A.
    Gray, R. J.
    Makower, D. F.
    Pritchard, K. I.
    Albain, K. S.
    Hayes, D. F.
    Geyer, C. E., Jr.
    Dees, E. C.
    Goetz, M. P.
    Olson, J. A., Jr.
    Lively, T.
    Badve, S. S.
    Saphner, T. J.
    Wagner, L. I.
    Whelan, T. J.
    Ellis, M. J.
    Paik, S.
    Wood, W. C.
    Ravdin, P. M.
    Keane, M. M.
    Moreno, H. L. Gomez
    Reddy, P. S.
    Goggins, T. F.
    Mayer, I. A.
    Brufsky, A. M.
    Toppmeyer, D. L.
    Kaklamani, V. G.
    Berenberg, J. L.
    Abrams, J.
    Sledge, G. W., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02) : 111 - 121
  • [7] Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
    Sparano, Joseph A.
    Crager, Michael R.
    Tang, Gong
    Gray, Robert J.
    Stemmer, Salomon M.
    Shak, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 557 - +
  • [8] Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
    Sparano, Joseph A.
    Gray, Robert J.
    Ravdin, Peter M.
    Makower, Della F.
    Pritchard, Kathleen I.
    Albain, Kathy S.
    Hayes, Daniel F.
    Geyer, Charles E., Jr.
    Dees, Elizabeth C.
    Goetz, Matthew P.
    Olson, John A., Jr.
    Lively, Tracy
    Badve, Sunil S.
    Saphner, Thomas J.
    Wagner, Lynne I.
    Whelan, Timothy J.
    Ellis, Matthew J.
    Paik, Soonmyung
    Wood, William C.
    Keane, Maccon M.
    Gomez Moreno, Henry L.
    Reddy, Pavan S.
    Goggins, Timothy F.
    Mayer, Ingrid A.
    Brufsky, Adam M.
    Toppmeyer, Deborah L.
    Kaklamani, Virginia G.
    Berenberg, Jeffrey L.
    Abrams, Jeffrey
    Sledge, George W., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (25) : 2395 - 2405
1